Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Dubreuil

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Heart (British Cardiac Society)|June 16, 2006
Adventitia measurement in coronary artery: an in vivo intravascular ultrasound studyG Rioufol, M Elbaz, O Dubreuil, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 26, 2007
Morphological and biomechanical aspects of vulnerable coronary plaqueG Finet, J Ohayon, G Rioufol, et al.
Gastroenterologie Clinique Et Biologique|August 16, 2008
[Case report: a voluminous colonic lipoma]G Lesur, P-H Bassot, O Dubreuil, et al.
Gastroenterologie Clinique Et Biologique|August 6, 2008
[Rectosigmoid junction metastasis from melanoma: a case report]G Lesur, I Bourgault, C Longvert, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 22, 2026
Dihydropyrimidine dehydrogenase phenotype-guided dose individualization of fluoropyrimidine in gastrointestinal cancers: PRODIGE100-UCGI48-FUDOSE phase II studyG M Camilleri, M A Loriot, G Le Teuff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 14, 2018
RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter studyJ B Bachet, O Bouché, J Taieb, et al.
ESMO Open|May 13, 2025
Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II studyE Samalin, L Evesque, A Turpin, et al.
ESMO Open|September 10, 2024
Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter studyC Gallois, E S Bergen, É Auclin, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Heart (British Cardiac Society)|June 16, 2006
Adventitia measurement in coronary artery: an in vivo intravascular ultrasound studyG Rioufol, M Elbaz, O Dubreuil, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 26, 2007
Morphological and biomechanical aspects of vulnerable coronary plaqueG Finet, J Ohayon, G Rioufol, et al.
Gastroenterologie Clinique Et Biologique|August 16, 2008
[Case report: a voluminous colonic lipoma]G Lesur, P-H Bassot, O Dubreuil, et al.
Gastroenterologie Clinique Et Biologique|August 6, 2008
[Rectosigmoid junction metastasis from melanoma: a case report]G Lesur, I Bourgault, C Longvert, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 22, 2026
Dihydropyrimidine dehydrogenase phenotype-guided dose individualization of fluoropyrimidine in gastrointestinal cancers: PRODIGE100-UCGI48-FUDOSE phase II studyG M Camilleri, M A Loriot, G Le Teuff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 14, 2018
RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter studyJ B Bachet, O Bouché, J Taieb, et al.
ESMO Open|May 13, 2025
Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II studyE Samalin, L Evesque, A Turpin, et al.
ESMO Open|September 10, 2024
Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter studyC Gallois, E S Bergen, É Auclin, et al.
Pageof 1